Phibro Animal Health | PAHC - Cash And Equivalent


Phibro Animal Health reported $54.93M in Cash and Equivalent for its fiscal quarter ending in March of 2026.





Cash And Equivalent Change Date
Align Technology USD 1.1B 42.76M Jun/2026
ANI Pharmaceuticals USD 360.21M 49.04M Jun/2026
Aurora Cannabis CAD 64.69M 8.33M Mar/2026
Bristol-Myers Squibb USD 8.72B 852M Jun/2026
Canopy Growth CAD 364.68M 6.64M Mar/2026
Corcept Therapeutics USD 111.04M 2.3M Jun/2026
Eli Lilly USD 8.95B 3.67B Jun/2026
Henry Schein USD 157M 19M Jun/2026
Idexx Laboratories USD 196.93M 3.6M Jun/2026
Knight Therapeutics CAD 76.45M 5.43M Dec/2025
Merck USD 6.85B 1.52B Jun/2026
Nektar Therapeutics USD 149.58M 134.46M Mar/2026
Pacira USD 205.88M 61.57M Jun/2026
Phibro Animal Health USD 54.93M 557K Mar/2026
Prestige Brands USD 89.13M 25.26M Jun/2026
Supernus Pharmaceuticals USD 179.95M 4.92M Jun/2026
Zoetis USD 1.48B 465M Jun/2026